Participants in the FORWARD-53 trial had clinically significant improvements in time-to-rise, among other metrics.
Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback